SCHEMBL5175656

SCHEMBL5175656

NC(=O)C(N[C@@H](c1ccccc1C(F)(F)F)S(=O)(=O)c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.44
CNR1 P21554 5/20 0.38
ACP3 P15309 1/20 0.38
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
USP2 O75604 1/20 0.36
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
HAT1 O14929 1/20 0.35
EP300 Q09472 1/20 0.35
FLT1 P17948 1/20 0.34
FLT4 P35916 1/20 0.34
KDR P35968 1/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
HPGD P15428 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5128164 0.90 PSEN1 (0.39) CNR2USP2MAPTNPSR1FNTA
SCHEMBL5122199 0.89 PSEN1 (0.40) CNR2USP2MAPTNPSR1FNTA
SCHEMBL5176805 0.85 FNTA (0.39) ACP3MAPTNPSR1FNTAFNTB
SCHEMBL5113412 0.85 SCN8A (0.38) CNR2CNR1PPARGUSP2MAPT
SCHEMBL5236529 0.85 AVPR2 (0.40) CNR2PPARAFNTAFNTB
SCHEMBL5175072 0.84 CNR2 (0.42) CNR2CNR1PPARGUSP2MAPT
SCHEMBL5113431 0.84 MAPT (0.41) CNR2PPARGUSP2MAPTNPSR1
SCHEMBL5121770 0.84 TRPM8 (0.39) CNR1USP2MAPTNPSR1FNTA
SCHEMBL5177320 0.84 FLT1 (0.40) CNR1NPSR1FNTAFNTBCA1
SCHEMBL5176207 0.82 PPARG (0.44) CNR2ACP3PPARGUSP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747195-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Pfizer Products Incorporated (US) 2007-01-31 EP claimed
WO-2005095334-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS PFIZER PRODUCTS INC. (US) 2005-10-13 WO claimed